Peter Reuter

Presents a concise, accessible, objective view of where the United States has been, now stands, and is going in the future in its long "war on drugs." The authors assess the success of drug policies to date and review possible reasons why they have not been more successful. They recommend management of the drug problem for the long term, use of different policy levers depending on the situation, and tolerance of cross-state policy variation.

Originally developed to reduce drug trafficking, national and international efforts to reduce money laundering have broadened over the years to address other crimes, and most recently, terrorism. These efforts now constitute a formidable regime applied to financial institutions and transactions throughout much of the world. Yet few assessments of either the achievements or consequences of this regime have been made. Reuter and Truman (1) explore what is know about the scale and characteristics of money laundering, (2) describe the current anti-money laundering regime, (3) develop a framework for assessing the effectiveness of the regime, and (4) use that framework to assess how well the current system works and make proposals for its improvement.

This book provides the first multidisciplinary and nonpartisan analysis of how the United States should decide on the legal status of cocaine, heroin and marijuana. It draws on data about the experiences of Western European nations with less punitive drug policies as well as new analyses of America’s experience with legal cocaine and heroin a century ago, and of America’s efforts to regulate gambling, prostitution, alcohol and cigarettes. It offers projections on the likely consequences of a number of different legalization regimes and shows that the choice about how to regulate drugs involves complicated tradeoffs among goals and conflict among social groups. The book presents a sophisticated discussion of how society should deal with the uncertainty about the consequences of legal change. Finally, it explains, in terms of individual attitudes toward risk, why it is so difficult to accomplish substantial reform of drug policy in America.

Birkh user s Dictionary of Human Biology is the most comprehensive English-German/ German-English dictionary on the international market. More than 60.000 entries and subentries with some 150.000 translations and an extent appendix with abbreviations and terminologia anatomica provide users with an unrivaled coverage of medical, biological and related bioscientific areas. The dictionary excels through a harmonious synthesis of biomedical and general bilingual dictionaries, making it the ideal choice for users from both scientific and linguistic fields. Furthermore, Birkh user s Dictionary of Human Biology is marked by a first class linguistic and lexicographic treatment and offers additional features, such as syllabification and pronounciation, that help in achieving a very high user friendliness and user satisfaction.

Birkhäuser's Pocket Dictionary of Biochemistry is the most comprehensive English-German/German-English dictionary on the international market. More than 30.000 entries and subentries with some 50.000 translations and an extent appendix with a specifically compiled list of abbreviations provide users with an unrivaled coverage of biochemistry and related bioscientific areas. The dictionary excels through a harmonious synthesis of biochemical and general bilingual dictionaries, making it the ideal choice for users from both scientific and linguistic fields. Furthermore Birkhäuser's Pocket Dictionary of Biochemistry is marked by a first class linguistic and lexicographic treatment achieving a very high user friendliness and user satisfaction. In the English-German part British terms have been included in addition to American terms, thus making it possible to find entries from either language.